MedPath

GLYBURIDE

Glyburide Tablets, USP 1.25, 2.5, and 5 mg

Approved
Approval ID

a4e77a68-fc90-4021-e053-2995a90a87df

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 20, 2023

Manufacturers
FDA

Denton Pharma, Inc. DBA Northwind Pharmaceuticals

DUNS: 080355546

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

GLYBURIDE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code70934-690
Application NumberANDA090937
Product Classification
M
Marketing Category
C73584
G
Generic Name
GLYBURIDE
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 20, 2023
FDA Product Classification

INGREDIENTS (5)

LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
FD&C RED NO. 40Inactive
Code: WZB9127XOA
Classification: IACT
GLYBURIDEActive
Quantity: 2.5 mg in 1 1
Code: SX6K58TVWC
Classification: ACTIB

Drug Labeling Information

DESCRIPTION SECTION

LOINC: 34089-3Updated: 4/5/2021

DESCRIPTION

Glyburide tablets, USP contain a smaller particle size glyburide, which is an oral blood-glucose-lowering drug of the sulfonylurea class. Glyburide is a white, crystalline compound, formulated as glyburide tablets, USP of 1.25, 2.5, and 5 mg strengths for oral administration. Inactive ingredients: lactose monohydrate, microcrystalline cellulose, magnesium stearate. In addition, the 2.5 mgcontains FD&C Red No.40 and the5 mg contains FD&C Blue No.1. The chemical name for glyburide is 1-[[p-[2-(5-chloro-o- anisamido)-ethyl]phenyl]-sulfonyl]-3-cyclohexylurea and the molecular weight is 493.99. The structural formula is represented below.

Image

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

GLYBURIDE - FDA Drug Approval Details